School of Medicine
Showing 111-120 of 122 Results
Pamela L. Kunz
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Bio Dr. Kunz specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors (NETs). She has developed broad investigative programs in the field of neuroendocrine tumors (NETs), encompassing clinical trials, population sciences, and translational correlates. Stanford has a robust referral base for neuroendocrine tumors and has demonstrated successful accrual to clinical trials in this rare disease. She has been involved with the design, development and conduct of Phase I, II, and III clinical trials in this field. She holds a number of leadership positions in the field including Vice Chair of the Neuroendocrine Tumor Taskforce of the National Cancer institute and member of the NANETS Board of Directors. She also serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel and the NET Working Group of the Eastern Cooperative Oncology Group (ECOG) and is the founding Director of the Stanford Neuroendocrine Tumor Program, established in 2015.
Maureen Lyles D'Ambrogio Professor
Current Research and Scholarly Interests We study cancer biology, intestinal stem cells (ISC), and angiogenesis. We use primary organoid cultures of diverse tissues and tumor biopsies for immunotherapy modeling, oncogene functional screening and stem cell biology. Angiogenesis projects include blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.
Clinical Assistant Professor (Affiliated) [Valley Care], Medicine - Med/Infectious Diseases
Bio Dr. Krutika Kuppalli is board certified in Internal Medicine and Infectious Diseases. Dr. Kuppalli grew up in the Bay Area and is excited to care for the community where she grew up. She has a passion for taking care of individuals with complex infections, particularly indigent patient populations. As an Infectious Diseases physician she is interested in infections of global importance and has spent time living and working overseas. Outside of work, Dr. Kuppalli enjoys yoga and spending time with her dogs.
Allison W. Kurian, M.D., M.Sc.
Associate Professor of Medicine (Oncology) and of Health Research and Policy at the Stanford University Medical Center
Current Research and Scholarly Interests I aim to improve the outcomes of women's cancers through clinically-oriented research on genetic risk assessment, risk-adapted screening and prevention.
Associate Professor (Teaching) of Medicine (Primary Care and Population Health)
Current Research and Scholarly Interests My research focuses on the physical and mental health of military service members.
Instructor, Medicine - Oncology
Current Research and Scholarly Interests Implementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.
Ware Kuschner, M.D.
Professor of Medicine (Pulmonary and Critical Care Medicine) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests Occupational and environmental lung disease; Pulmonary and systemic responses to toxicant inhalation; Indoor and outdoor air pollution health effects;
Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center
Bio Dr. Kwo is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.